3Williamson P J, Kruger A R, Reynolds P J, et al. Establishing the incidence of myelodysplastic syndrome.Br J Haematol, 1994, 87:743-745.
4Chan G, DiVenuti G, Miller K. Danazol for the treatment of thrombocytopenia in patients with myelodysplastic syndrome. Am J Hematol, 2002, 71 :166-171.
5Steensma D P, Dispenzieri A, Moore S B, et al. Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome. Blood, 2003, 101:2156-2158.
6Bennett J M. World Health Organization classification of the acute leukemias and myelodysplastic syndrome.Int J Hematol, 2000, 72:131-133.
7Lambertenghi Delliers G, Orazi A, Luksch R, et al.Myelodysplastic syndrome with increased marrow fibrosis. A distinct clinicopathological entity. Br J Haematol,1991,78:161-161.
